repair-maintenance Altimmune, Inc. (ALT) Discusses Topline 48-Week Results From IMPACT Phase IIb Trial of Pemvidutide in MASH – Slideshow 12월 20, 2025 📋 Altimmune, Inc. (ALT) Discusses Topline 48-Week Results From...Read More
repair-maintenance Kyverna to present topline results from Phase 2 trial in stiff person syndrome 12월 14, 2025 📋 Kyverna to present topline results from Phase 2...Read More